This article is part of the supplement: Proceedings of the Fifth International Society of Sports Nutrition (ISSN) Conference and Expo
The effect of Russian Tarragon (artemisia dracunculus L.) on the plasma creatine concentration with creatine monohydrate administration
-
* Corresponding author: Ralf Jäger ralf.jaeger@increnovo.com
1 Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, WI 53202, USA
2 School of Sport, Exercise and Health Sciences, University of Chichester, PO19 6PE, UK
3 Biotech Center, Cook College, Rutgers University, New Brunswick, NJ 08901-8520, USA
4 PhytoLab GmbH & Co. KG, Dutendorfer Straße 5-7, 91487 Vestenbergsgreuth, Germany
Journal of the International Society of Sports Nutrition 2008, 5(Suppl 1):P4 doi:10.1186/1550-2783-5-S1-P4
Published: 17 September 2008First paragraph (this article has no abstract)
It has previously been shown that the plasma concentration of creatine following supplementation is influenced by extracellular concentrations of insulin and glucose, the form in which creatine is administered, and also the creatine concentration in the muscle cells. The common practice of raising insulin levels to increase initial uptake into muscle, by means of high amounts of glucose and/or protein, involves a high caloric load which is not always desired by athletes. A standardized extract of Russian Tarragon (Artemisia dracunculus L.), which can be administered safely as an oral supplement, has been shown to have antihyperglycemic activity. This study examined whether the plasma concentration curve following administration of creatine monohydrate was affected by the co-administration of Russian Tarragon extract.